How We Chose
We tracked funding rounds, company-reported growth figures, and launches from companies selling AI products to healthcare between September 22 and October 27, 2026, using company announcements and news coverage. Most growth figures are company-reported, and we say so in each entry. Entries are in alphabetical order.
Healthcare AI Companies to Watch (November 2026)
| # | Name | Company | Why now |
|---|
| 1 | Basalt Health | Post-acute admissions AI | $20M Series A led by NEA, Sep 24 |
| 2 | Confido Health | Practice operations AI | $12.5M Series A extension led by Z47, Oct 14 |
| 3 | Healthleap | Inpatient risk detection | $38M seed and Series A, reported Oct 7 |
| 4 | Heidi Health | AI clinical documentation | $100M Series C at $900M valuation, Sep 22 |
| 5 | Parakeet Health | AI patient access | $10M Series A led by Canvas Ventures, Oct 1 |
| 6 | Readily | Regulatory compliance AI | $11M Series A led by Define Ventures, Oct 13 |
| 7 | Sirona Medical | Cloud radiology software | $40M Series D led by Avidity Partners, Oct 15 |
| 8 | Suki | Ambient clinical AI | $90M Series E led by Healthier Capital, Oct 13 |
| 9 | Vera Health | Clinical evidence search | $28.5M Series A led by Threshold Ventures, Oct 27 |
| 10 | Vitalize | Workforce and capacity AI | $31M Series A led by Oak HC/FT, Oct 6 |
86%Cut in median referral processing time at Lifepoint Health
1. Basalt Health
AI for post-acute admissions
- Company
- Basalt Health
- Why now
- Announced a $20 million Series A on September 24, 2026.
Ben Hackett, who spent nearly a decade at Accolade, founded Basalt in 2024. Its AI reads referral packets for rehab and skilled nursing admissions and checks them against clinical and payer rules. At Lifepoint Health, median processing time fell from 8.5 minutes to 1.2 minutes, according to the Series A announcement.
Why now
NEA led the round, and partner Blake Wu sits on the board. Basalt is rolling out to 111 Lifepoint and ScionHealth markets by the end of 2026. Two health systems account for most of its public results, so those rollouts are the test.
Basalt Health reviewBen Hackett profileBlake Wu profile
15xGrowth since its previous round, per Confido
2. Confido Health
AI agents for practice operations
- Company
- Confido Health
- Why now
- Announced a $12.5 million Series A extension on October 14, 2026.
Confido's AI agents answer and place patient calls and handle scheduling, insurance checks, referrals, refills, and payments across more than 50 connected systems. It sells to private equity firms first and then to the specialty practices they own, according to its announcement.
Why now
Z47, formerly Matrix Partners India, led the extension, bringing the Series A to $22.5 million. A customer CFO at Vision Innovation Partners said collections doubled, but Confido's 95% task-completion rate and growth figures are its own.
Confido Health review
50+Hospitals using it, up from three a year earlier
3. Healthleap
Inpatient risk detection
- Company
- Healthleap
- Why now
- TechCrunch reported $38 million in funding on October 7, 2026.
Siblings Josiah Meyer and Jemima Meyer, from South Africa, built Healthleap to read every adult inpatient chart overnight and flag patients who may have undiagnosed malnutrition, delirium, and other conditions. Customers include Penn Medicine and Cedars-Sinai, according to TechCrunch.
Why now
The funding combined an $8 million seed co-led by Sequoia Capital and First Round Capital and a $30 million Series A led by Hummingbird Ventures. The company says one Penn hospital saw $23.8 million in annualized financial impact from its malnutrition program. That figure is Healthleap's own, and its newer condition programs are still being validated.
Healthleap reviewJosiah Meyer profile
$50MAnnual recurring revenue in April 2026, up from $1M two years earlier
4. Heidi Health
AI clinical documentation
- Company
- Heidi Health
- Why now
- Announced a $100 million Series C on September 22, 2026.
Heidi, led by co-founder and chief executive Dr. Thomas Kelly, makes an AI scribe and assistant that it says has supported more than 175 million patient visits in 190 countries and 110 languages, up from 73 million at its Series B, according to its announcement.
Why now
Blackbird led the Series C at a $900 million valuation, and General Catalyst's Customer Value Fund added a separate $240 million growth investment for sales and marketing. Heidi plans to move from writing notes to taking supervised actions after visits, which raises the bar for clinical safety.
Heidi Health review
10xAnnual recurring revenue growth in a year, per Parakeet
5. Parakeet Health
AI patient access
- Company
- Parakeet Health
- Why now
- Announced a $10 million Series A on October 1, 2026.
Led by co-founder and chief executive Jung Park, Parakeet handles inbound calls, outreach, fax processing, and online scheduling, and says it serves six of the 10 largest dermatology groups in the U.S., according to its announcement.
Why now
Canvas Ventures led the round, bringing total funding to $13 million. Parakeet grew on little capital, and the round pays for a move into more specialties. It remains small next to better-funded voice AI rivals.
Parakeet Health reviewJung Park profile
25M+Covered lives supported across 46 states
6. Readily
Regulatory compliance AI
- Company
- Readily
- Why now
- Announced an $11 million Series A on October 13, 2026.
Founded by Edward Tiong, a former Microsoft AI scientist, Readily links rule changes to a health plan's policies, tasks, audits, and evidence. Customers include L.A. Care Health Plan, state agencies, and physician groups, according to its announcement.
Why now
Define Ventures led the round, with Y Combinator and the California Health Care Foundation Innovation Fund. Readily is raising as federal penalties on health plans climb, and it says it has cut regulatory analysis and audit work by up to 90%. That figure is its own, and its broader oversight product is not yet on the market.
Readily reviewEdward Tiong profile
2.5xGrowth in usage and annual recurring revenue, per Sirona
7. Sirona Medical
Cloud radiology software
- Company
- Sirona Medical
- Why now
- Announced a $40 million Series D on October 15, 2026.
Founded by Cameron Andrews in 2018, Sirona makes RadOS, which puts image storage, viewing, reporting, worklists, and AI on one cloud platform. It has more than 12 million imaging exams a year under contract, according to its announcement.
Why now
Avidity Partners led the round, with 8VC, GreatPoint Ventures, KLT Holdings, and Rose Park Advisors. Sirona says the money funds its operating plan indefinitely and plans an international program before the end of 2026. Radiology platforms take months to deploy, so contracted volume will take time to show up as revenue.
Sirona Medical reviewCameron Andrews profile
450+Healthcare organizations using Suki
8. Suki
Ambient clinical AI
- Company
- Suki
- Why now
- Announced a $90 million Series E on October 13, 2026.
Founded by Punit Soni, Suki makes AI for clinical documentation, coding, and clinical reasoning, and more than 30 technology partners build it into their own products. It says revenue doubled in 2025, according to its announcement.
Why now
Healthier Capital led the round, and partner Aman Mahajan joined the board. Suki competes with larger ambient scribe companies, and its plan relies on partners putting its AI in front of more clinicians.
Suki reviewAman Mahajan profile
800,000+Clinicians using it, up from a few thousand a year earlier
9. Vera Health
Clinical evidence search
- Company
- Vera Health
- Why now
- Announced a $28.5 million Series A on October 27, 2026.
Vera searches more than 60 million papers, guidelines, and drug labels, and color-codes the strength of evidence behind each claim in its answers. It is free for clinicians and reaches users in 190 countries with 12 employees, according to its announcement.
Why now
Threshold Ventures led the round, with co-founder Emily Melton backing it, bringing total funding to $32 million. Vera plans deeper partnerships with medical societies, publishers, and health systems, and its clinical reasoning studies at academic centers are still under way.
Vera Health reviewEmily Melton profile
54%Cut in premium labor spend in 12 weeks at St. Luke's Health
10. Vitalize
Workforce and capacity AI
- Company
- Vitalize
- Why now
- Announced a $31 million Series A on October 6, 2026.
Founded in 2021 by Veeraj Shah and Sanketh Andhavarapu, Vitalize schedules nurses and other staff and matches staffing to bed capacity. It says it manages millions of shifts a week across dozens of health systems, according to the Oak HC/FT announcement.
Why now
Oak HC/FT led the round, and partner Vig Chandramouli called labor a nearly trillion-dollar line item for U.S. health systems. The 54% figure comes from a St. Luke's executive quoted in the announcement, not an independent study.
Vitalize reviewVeeraj Shah profileVig Chandramouli profile
What to Watch Next Month
- Sirona goes international. Sirona Medical plans to launch an international program before the end of 2026.
- Basalt's network rollout. Basalt Health is due to reach 111 Lifepoint and ScionHealth markets by the end of 2026.
- Healthleap's new conditions. Healthleap is validating programs beyond malnutrition as it heads toward more than 40 conditions.
The Healthcare AI Companies to Watch list is updated monthly. This is the first edition. Past editions will be linked here, and every HIR list and report is in our research library.
